PubRank

M M Lai

Author PubWeight™ 309.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell 1977 7.23
2 Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 1999 6.21
3 Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature 1987 4.52
4 Adenylic acid-rich sequence in RNAs of Rous sarcoma virus and Rauscher mouse leukaemia virus. Nature 1972 4.49
5 RNA of mouse hepatitis virus. J Virol 1978 4.27
6 The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology 1991 4.07
7 Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol 1981 4.00
8 Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A 1984 3.81
9 Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci U S A 1989 3.51
10 Avian tumor virus RNA: a comparison of three sarcoma viruses and their transformation-defective derivatives by oligonucleotide fingerprinting and DNA-RNA hybridization. Proc Natl Acad Sci U S A 1973 3.46
11 Ribonucleic acid components of murine sarcoma and leukemia viruses. Proc Natl Acad Sci U S A 1973 3.42
12 Putative papain-related thiol proteases of positive-strand RNA viruses. Identification of rubi- and aphthovirus proteases and delineation of a novel conserved domain associated with proteases of rubi-, alpha- and coronaviruses. FEBS Lett 1991 3.35
13 Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol 1988 3.11
14 Presence of leader sequences in the mRNA of mouse hepatitis virus. J Virol 1983 3.06
15 High-frequency RNA recombination of murine coronaviruses. J Virol 1986 2.91
16 Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. J Virol 1982 2.86
17 Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J Virol 1983 2.80
18 Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J Virol 1982 2.46
19 The 3'-untranslated region of hepatitis C virus RNA enhances translation from an internal ribosomal entry site. J Virol 1998 2.36
20 Further characterization of mRNA's of mouse hepatitis virus: presence of common 5'-end nucleotides. J Virol 1982 2.34
21 Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology 1999 2.33
22 Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol 1981 2.30
23 Restriction enzyme sites on the avian RNA tumor virus genome. J Virol 1978 2.29
24 Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 1998 2.28
25 Determination of the secondary structure of and cellular protein binding to the 3'-untranslated region of the hepatitis C virus RNA genome. J Virol 1997 2.28
26 Occurrence of partial deletion and substitution of the src gene in the RNA genome of avian sarcoma virus. Proc Natl Acad Sci U S A 1977 2.22
27 Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol 1985 2.21
28 The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology 1987 2.17
29 Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol 1990 2.17
30 Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A 1986 2.16
31 A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J Virol 1999 2.16
32 Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology 1983 2.11
33 Phosphoproteins of murine hepatitis viruses. J Virol 1979 2.07
34 Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Res 1985 2.07
35 High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J Virol 1989 1.95
36 An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence. Virology 1999 1.90
37 Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase. J Virol 1987 1.89
38 Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal. J Virol 1990 1.88
39 Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology 1988 1.87
40 Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol 1997 1.84
41 Identification of a domain required for autoproteolytic cleavage of murine coronavirus gene A polyprotein. J Virol 1989 1.82
42 Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J Virol 1989 1.77
43 Discontinuous transcription generates heterogeneity at the leader fusion sites of coronavirus mRNAs. J Virol 1988 1.76
44 Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J Virol 1992 1.75
45 Identification of the catalytic sites of a papain-like cysteine proteinase of murine coronavirus. J Virol 1993 1.74
46 Differential subcellular localization of hepatitis C virus core gene products. Virology 1995 1.73
47 Defective-interfering particles of murine coronavirus: mechanism of synthesis of defective viral RNAs. Virology 1988 1.73
48 Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J Virol 1993 1.71
49 Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc Natl Acad Sci U S A 1997 1.70
50 An in vitro system for the leader-primed transcription of coronavirus mRNAs. EMBO J 1990 1.69
51 Genome of avian myelocytomatosis virus MC29: analysis by heteroduplex mapping. Proc Natl Acad Sci U S A 1979 1.68
52 Phosphoproteins of Rous sarcoma viruses. Virology 1976 1.67
53 Colocalization and membrane association of murine hepatitis virus gene 1 products and De novo-synthesized viral RNA in infected cells. J Virol 1999 1.67
54 Differences between the envelope glycoproteins and glycopeptides of avian tumor viruses released from transformed and from nontransformed cells. Virology 1972 1.67
55 Further characterization of mouse hepatitis virus RNA-dependent RNA polymerases. Virology 1984 1.64
56 Three different cellular proteins bind to complementary sites on the 5'-end-positive and 3'-end-negative strands of mouse hepatitis virus RNA. J Virol 1993 1.64
57 Identification of the cis-acting signal for minus-strand RNA synthesis of a murine coronavirus: implications for the role of minus-strand RNA in RNA replication and transcription. J Virol 1994 1.64
58 Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex. J Virol 1992 1.63
59 Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J Gen Virol 1982 1.62
60 Heterogeneity of gene expression of the hemagglutinin-esterase (HE) protein of murine coronaviruses. Virology 1991 1.60
61 Reversible cleavage and ligation of hepatitis delta virus RNA. Science 1989 1.59
62 Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. J Virol 1994 1.58
63 RNA-binding activity of hepatitis delta antigen involves two arginine-rich motifs and is required for hepatitis delta virus RNA replication. J Virol 1993 1.57
64 Random nature of coronavirus RNA recombination in the absence of selection pressure. Virology 1991 1.57
65 Sequence conservation and divergence of hepatitis delta virus RNA. Virology 1990 1.56
66 Analysis of intracellular small RNAs of mouse hepatitis virus: evidence for discontinuous transcription. Virology 1987 1.52
67 Transcription of hepatitis delta antigen mRNA continues throughout hepatitis delta virus (HDV) replication: a new model of HDV RNA transcription and replication. J Virol 1998 1.51
68 Homotypic interaction and multimerization of hepatitis C virus core protein. Virology 1996 1.51
69 Template requirement and initiation site selection by hepatitis C virus polymerase on a minimal viral RNA template. J Biol Chem 2000 1.46
70 Sequence and structure of the catalytic RNA of hepatitis delta virus genomic RNA. J Mol Biol 1992 1.44
71 17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer. Int Braz J Urol 2005 1.44
72 Evolution of the 5'-end of genomic RNA of murine coronaviruses during passages in vitro. Virology 1989 1.43
73 Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling. Science 1999 1.42
74 Immunophilins in the nervous system. Neuron 1998 1.42
75 Requirement of the 5'-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J Virol 1994 1.41
76 Heterogeneous nuclear ribonucleoprotein a1 binds to the 3'-untranslated region and mediates potential 5'-3'-end cross talks of mouse hepatitis virus RNA. J Virol 2001 1.41
77 Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus. EMBO J 2000 1.38
78 Neurabin is a synaptic protein linking p70 S6 kinase and the neuronal cytoskeleton. Proc Natl Acad Sci U S A 1998 1.38
79 Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression. J Neurovirol 1995 1.37
80 RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases. Mol Cell Biol 2000 1.36
81 A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc Natl Acad Sci U S A 1995 1.34
82 Replication of hepatitis delta virus RNA: effect of mutations of the autocatalytic cleavage sites. J Virol 1993 1.34
83 Hepatitis C virus NS5B protein is a membrane-associated phosphoprotein with a predominantly perinuclear localization. Virology 1997 1.33
84 In vivo RNA-RNA recombination of coronavirus in mouse brain. J Virol 1988 1.33
85 Multiple recombination sites at the 5'-end of murine coronavirus RNA. Virology 1987 1.32
86 Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen. J Virol 1992 1.32
87 Chromosome 1 contains the endogenous RAV-0 retrovirus sequences in chicken cells. Proc Natl Acad Sci U S A 1979 1.32
88 Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. J Biol Chem 1998 1.32
89 RNA conformational requirements of self-cleavage of hepatitis delta virus RNA. Mol Cell Biol 1990 1.30
90 In vitro synthesis and characterisation of full- and half-genome length complementary DNA from avian oncoviruses. Nature 1978 1.29
91 Avian erythroblastosis virus: transformation-specific sequences form a contiguous segment of 3.25 kb located in the middle of the 6-kb genome. Virology 1979 1.29
92 Polypyrimidine tract-binding protein binds to the leader RNA of mouse hepatitis virus and serves as a regulator of viral transcription. J Virol 1999 1.28
93 Sequence analysis of nucleocapsid gene and leader RNA of human coronavirus OC43. Virus Res 1989 1.27
94 Linezolid-induced optic neuropathy: a mitochondrial disorder? Br J Ophthalmol 2007 1.26
95 Avian reticuloendotheliosis virus contains a new class of oncogene of turkey origin. Virology 1981 1.26
96 Mouse hepatitis virus S RNA sequence reveals that nonstructural proteins ns4 and ns5a are not essential for murine coronavirus replication. J Virol 1991 1.25
97 A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication. J Virol 1996 1.25
98 Heterogeneity of hepatitis delta antigen. Virology 1990 1.23
99 The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: implications for the requirement of a second factor for viral infection. J Virol 1992 1.22
100 Unusual heterogeneity of leader-mRNA fusion in a murine coronavirus: implications for the mechanism of RNA transcription and recombination. J Virol 1994 1.21
101 Recommendations of the Coronavirus Study Group for the nomenclature of the structural proteins, mRNAs, and genes of coronaviruses. Virology 1990 1.21
102 Cell-free translation of avian erythroblastosis virus RNA yields two specific and distinct proteins with molecular weights of 75,000 and 40,000. Virology 1980 1.21
103 Interactions between the cytoplasmic proteins and the intergenic (promoter) sequence of mouse hepatitis virus RNA: correlation with the amounts of subgenomic mRNA transcribed. J Virol 1995 1.21
104 A clustering of RNA recombination sites adjacent to a hypervariable region of the peplomer gene of murine coronavirus. Virology 1990 1.20
105 RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. J Virol 1988 1.19
106 Biosynthesis, structure, and biological activities of envelope protein gp65 of murine coronavirus. Virology 1989 1.19
107 Neural actions of immunophilin ligands. Trends Pharmacol Sci 1998 1.18
108 Molecular cloning and characterization of an isolate of hepatitis delta virus from Taiwan. Hepatology 1991 1.17
109 Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen. J Virol 1993 1.15
110 Hepatitis delta antigen expressed by recombinant baculoviruses: comparison of biochemical properties and post-translational modifications between the large and small forms. Virology 1992 1.14
111 A spike protein-dependent cellular factor other than the viral receptor is required for mouse hepatitis virus entry. Virology 1993 1.14
112 The genomic RNA of avian reticuloendotheliosis virus REV. Virology 1980 1.14
113 Avian reticuloendotheliosis virus: characterization of genome structure by heteroduplex mapping. J Virol 1981 1.14
114 The 3' untranslated region of coronavirus RNA is required for subgenomic mRNA transcription from a defective interfering RNA. J Virol 1996 1.14
115 Synthesis and subcellular localization of the murine coronavirus nucleocapsid protein. Virology 1983 1.13
116 Generation and selection of coronavirus defective interfering RNA with large open reading frame by RNA recombination and possible editing. Virology 1993 1.13
117 Evolution of hepatitis delta virus RNA during chronic infection. Virology 1992 1.13
118 Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain. J Virol 2001 1.13
119 Coronavirus leader-RNA-primed transcription: an alternative mechanism to RNA splicing. Bioessays 1986 1.12
120 A unique conformation at the carboxyl terminus of the small hepatitis delta antigen revealed by a specific monoclonal antibody. Virology 1993 1.12
121 Isoprenylation of large hepatitis delta antigen is necessary but not sufficient for hepatitis delta virus assembly. Virology 1994 1.12
122 Novel N-hydroxyguanidine derivatives as anticancer and antiviral agents. J Med Chem 1984 1.12
123 Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA. J Virol 1998 1.12
124 Protein 4.1N binding to nuclear mitotic apparatus protein in PC12 cells mediates the antiproliferative actions of nerve growth factor. J Neurosci 1999 1.11
125 RNA recombination of coronaviruses: localization of neutralizing epitopes and neuropathogenic determinants on the carboxyl terminus of peplomers. Proc Natl Acad Sci U S A 1987 1.11
126 Endogenous promoters can direct the transcription of hepatitis delta virus RNA from a recircularized cDNA template. Virology 1993 1.11
127 Polypyrimidine tract-binding protein binds to the complementary strand of the mouse hepatitis virus 3' untranslated region, thereby altering RNA conformation. J Virol 1999 1.10
128 Hepatitis delta antigens enhance the ribozyme activities of hepatitis delta virus RNA in vivo. J Virol 1996 1.09
129 Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. J Virol 1993 1.09
130 Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting neuropathogenicity. Virology 1992 1.08
131 Coronavirus mRNA transcription: UV light transcriptional mapping studies suggest an early requirement for a genomic-length template. J Virol 1992 1.07
132 The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication. J Virol 2000 1.07
133 Sequence analysis of the nucleocapsid protein gene of human coronavirus 229E. Virology 1989 1.06
134 Localization of extensive deletions in the structural genes of two neurotropic variants of murine coronavirus JHM. Virology 1991 1.05
135 Coronavirus mRNA synthesis: identification of novel transcription initiation signals which are differentially regulated by different leader sequences. Virology 1992 1.05
136 Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor. Virology 2001 1.05
137 RNA recombination in a coronavirus: recombination between viral genomic RNA and transfected RNA fragments. J Virol 1992 1.03
138 Isoprenylation masks a conformational epitope and enhances trans-dominant inhibitory function of the large hepatitis delta antigen. J Virol 1994 1.03
139 Characterization of the env gene in avian oncoviruses by heteroduplex mapping. J Virol 1978 1.02
140 Cell fusion studies identified multiple cellular factors involved in mouse hepatitis virus entry. Virology 1993 1.01
141 Determinants of coronavirus MHV pathogenesis are localized to 3' portions of the genome as determined by ribonucleic acid-ribonucleic acid recombination. Lab Invest 1990 1.01
142 Neural roles of immunophilins and their ligands. Mol Neurobiol 1997 1.00
143 Sequence analysis of the S gene of recombinant MHV-2/A59 coronaviruses reveals three candidate mutations associated with demyelination and hepatitis. J Neurovirol 2001 0.99
144 The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene. J Biol Chem 1999 0.99
145 Transgenic mice support replication of hepatitis delta virus RNA in multiple tissues, particularly in skeletal muscle. J Virol 1995 0.99
146 Expression of the hepatitis delta virus large and small antigens in transgenic mice. J Virol 1994 0.99
147 Inhibition of Cellular RNA polymerase II transcription by delta antigen of hepatitis delta virus. Virology 1998 0.97
148 Hepatitis delta virus: the molecular basis of laboratory diagnosis. Crit Rev Clin Lab Sci 2000 0.97
149 Coronavirus defective-interfering RNA as an expression vector: the generation of a pseudorecombinant mouse hepatitis virus expressing hemagglutinin-esterase. Virology 1995 0.97
150 Characterization of the transformation-specific sequences of avian erythroblastosis virus in normal vertebrate cells. Virology 1981 0.96
151 Role of polypyrimidine tract binding protein in the function of the hepatitis B virus posttranscriptional regulatory element. J Virol 2001 0.96
152 Characterization of genome structure of amphotropic and ecotropic wild mouse retroviruses. J Virol 1982 0.95
153 Recombinant hepatitis delta antigen from E. coli promotes hepatitis delta virus RNA replication only from the genomic strand but not the antigenomic strand. Virology 2000 0.95
154 Expression of hemagglutinin/esterase by a mouse hepatitis virus coronavirus defective-interfering RNA alters viral pathogenesis. Virology 1998 0.95
155 Human carcinoembryonic antigen and biliary glycoprotein can serve as mouse hepatitis virus receptors. J Virol 1997 0.95
156 Temporal regulation of bovine coronavirus RNA synthesis. Virus Res 1988 0.95
157 Natural evolution of coronavirus defective-interfering RNA involves RNA recombination. Virology 1993 0.93
158 Design, synthesis, testing, and quantitative structure-activity relationship analysis of substituted salicylaldehyde Schiff bases of 1-amino-3-hydroxyguanidine tosylate as new antiviral agents against coronavirus. J Med Chem 1990 0.91
159 Hepatitis C virus and interferon resistance. Microbes Infect 2000 0.91
160 Characterization of mRNA for hepatitis delta antigen: exclusion of the full-length antigenomic RNA as an mRNA. Virology 1998 0.91
161 A cis-acting viral protein is not required for the replication of a coronavirus defective-interfering RNA. Virology 1995 0.90
162 Replication of hepatitis delta virus RNA in mice after intramuscular injection of plasmid DNA. J Virol 1995 0.90
163 Hemagglutinin-esterase-specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus. J Virol 1992 0.90
164 Expression of interferon-gamma by a coronavirus defective-interfering RNA vector and its effect on viral replication, spread, and pathogenicity. Virology 1997 0.89
165 Genomic characterization of a highly oncogenic env gene recombinant between amphotropic retrovirus of wild mouse and endogenous xenotropic virus of NIH swiss mouse. Virology 1982 0.89
166 The detection and characterization of multiple hemagglutinin-esterase (HE)-defective viruses in the mouse brain during subacute demyelination induced by mouse hepatitis virus. Virology 1993 0.89
167 Variability of persisting MHV RNA sequences constituting immune and replication-relevant domains. Virology 1998 0.89
168 Formation of a ribonucleoprotein complex of mouse hepatitis virus involving heterogeneous nuclear ribonucleoprotein A1 and transcription-regulatory elements of viral RNA. Virology 1999 0.86
169 Apoptosis and viral hepatitis. Semin Liver Dis 1998 0.86
170 Mouse hepatitis virus strain JHM infects a human hepatocellular carcinoma cell line. Virology 1999 0.85
171 Murine coronavirus gene 1 polyprotein contains an autoproteolytic activity. Adv Exp Med Biol 1990 0.85
172 Avian RNA tumor virus DNA before and after integration into the host genome. Cold Spring Harb Symp Quant Biol 1979 0.85
173 Observation of two-photon absorption at low power levels using tapered optical fibers in rubidium vapor. Phys Rev Lett 2010 0.85
174 Epitopes exposed on hepatitis delta virus ribonucleoproteins. J Virol 1996 0.85
175 Regulation of prostatic acid phosphatase expression and secretion by androgen in LNCaP human prostate carcinoma cells. Arch Biochem Biophys 1993 0.85
176 Isolation and characterization of new ecotropic murine leukemia viruses after passage of an amphotropic virus in NIH Swiss mice. Virology 1983 0.83
177 Sequence analysis of the membrane protein gene of human coronavirus 229E. Virology 1990 0.83
178 Phosphorylation of the mouse hepatitis virus nucleocapsid protein. Biochem Biophys Res Commun 1986 0.83
179 Class II defective avian sarcoma viruses: comparative analysis of genome structure. Virology 1982 0.82
180 A 5'-proximal RNA sequence of murine coronavirus as a potential initiation site for genomic-length mRNA transcription. J Virol 1996 0.82
181 RNA recombination of coronavirus. Adv Exp Med Biol 1987 0.82
182 Comparison of the presence of two forms of delta antigen in liver tissues of acute versus chronic delta hepatitis. Prog Clin Biol Res 1993 0.81
183 Cell oncogenes are located on the large microchromosomes in chicken cells. Virology 1982 0.80
184 Characterization of transformation- and replication-specific sequences of reticuloendotheliosis virus. Virology 1981 0.80
185 Studies into the mechanism of MHV transcription. Adv Exp Med Biol 1987 0.80
186 Major phosphoprotein of avian sarcoma virus: peptide analysis of the variously charged species. Biochem Biophys Res Commun 1977 0.79
187 Association between serum uric acid and cardiovascular risk factors among elderly people in Taiwan. Kaohsiung J Med Sci 1999 0.79
188 Regulation of coronavirus RNA transcription is likely mediated by protein-RNA interactions. Adv Exp Med Biol 1995 0.79
189 Nucleoside kinase activities of Chinese hamster ovary cells. Biochim Biophys Acta 1983 0.79
190 Genetic heterogeneity of murine coronaviruses. Arch Virol 1983 0.79
191 Genome structure of mouse hepatitis virus: comparative analysis by oligonucleotide mapping. Adv Exp Med Biol 1981 0.79
192 Studies on the mechanism of RNA synthesis of a murine coronavirus. Adv Exp Med Biol 1984 0.78
193 Mouse hepatitis virus receptors: more than a single carcinoembryonic antigen. Arch Virol Suppl 1994 0.78
194 Cellular protein hnRNP-A1 interacts with the 3'-end and the intergenic sequence of mouse hepatitis virus negative-strand RNA to form a ribonucleoprotein complex. Adv Exp Med Biol 1998 0.78
195 Virus RNA species in kirsten murine sarcoma virus-transformed mink cells. J Gen Virol 1980 0.77
196 Identification of promoters of hepatitis delta virus RNA transcription on hepatitis delta virus cDNA. Prog Clin Biol Res 1993 0.77
197 Optimization of the Schiff bases of N-hydroxy-N'-aminoguanidine as anticancer and antiviral agents. J Med Chem 1985 0.77
198 Action of 2-beta-d-Ribofuranosylthiazole-4-carboxamide (tiazofurin) in Chinese hamster ovary and variant cell lines. Mol Pharmacol 1983 0.77
199 Regulation of mouse hepatitis virus RNA synthesis by heterogeneous nuclear ribonucleoprotein A1. Adv Exp Med Biol 2001 0.77
200 Avian oncovirus MH2: preferential growth in macrophages and exact size of the genome. Virology 1979 0.77
201 Hepatitis C viral RNA: challenges and promises. Cell Mol Life Sci 2001 0.77
202 Inhibition of murine coronavirus RNA synthesis by hydroxyguanidine derivatives. Virus Res 1989 0.77
203 Acinetobacter baumannii bloodstream infection: clinical features and antimicrobial susceptibilities of isolates. Kaohsiung J Med Sci 1999 0.77
204 The Coronaviridae now comprises two genera, coronavirus and torovirus: report of the Coronaviridae Study Group. Adv Exp Med Biol 1993 0.77
205 Murine coronavirus 5'-end genomic RNA sequence reveals mechanism of leader-primed transcription. Adv Exp Med Biol 1987 0.76
206 Using a defective-interfering RNA system to express the HE protein of mouse hepatitis virus for studying viral pathogenesis. Adv Exp Med Biol 1998 0.76
207 Mouse hepatitis virus infection utilizes more than one receptor and requires an additional cellular factor. Adv Exp Med Biol 1993 0.76
208 Genome structure of the defective avian sarcoma virus PRCIV. Virology 1982 0.76
209 Viral evolution and CTL epitope stability during JHMV infection in the central nervous system. Adv Exp Med Biol 1998 0.76
210 Hepatitis viruses and signal transduction: true to the core? Hepatology 2000 0.76
211 Hypertension and its related factors in Taiwanese elderly people. Yale J Biol Med 2001 0.75
212 Hypercholesterolemia and its correlates in Taiwanese elderly people. Yale J Biol Med 2001 0.75
213 Post-earthquake illness and disease after the Chi-Chi earthquake. Eur J Intern Med 2000 0.75
214 Tumor virus RNAs tumor virus genes. Hamatol Bluttransfus 1974 0.75
215 Glomerular diseases in Chinese from southern provinces. Chin Med J (Engl) 1988 0.75
216 Defective interfering particles of coronavirus. Adv Exp Med Biol 1987 0.75
217 Mouse hepatitis virus infection induces an early, transient calcium influx in mouse astrocytoma cells. Exp Cell Res 1997 0.75
218 Molecular cloning and sequence analysis of an isolate of hepatitis C virus from Southern California, U.S.A. J Formos Med Assoc 1992 0.75
219 Serum cholesterol levels and prevalence of hypercholesterolemia in school-aged Taiwanese children and adolescents: the Taichung Study. Zhonghua Yi Xue Za Zhi (Taipei) 1999 0.75
220 Murine hepatitis virus JHM variants isolated from Wistar Furth rats with viral-induced neurological disease. Adv Exp Med Biol 1990 0.75
221 Studies of coronavirus DI RNA replication using in vitro constructed DI cDNA clones. Adv Exp Med Biol 1990 0.75
222 The Nineteenth United States-Japan Joint Hepatitis Panel Meeting. Hepatology 1998 0.75
223 Site-specific sequence repair of coronavirus defective interfering RNA by RNA recombination and edited RNA. Adv Exp Med Biol 1993 0.75
224 Attenuation of avian reticuloendotheliosis virus: loss of the defective transforming component during serial passage of oncogenic virus in fibroblasts. Virology 1980 0.75
225 Temporal regulation of RNA synthesis of bovine coronavirus. Adv Exp Med Biol 1987 0.75